XCath
PrivateLast Round
Series C
Mar 12, 2026
Total Funding Raised
$30M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
XCath is a medical device company that develops next-generation endovascular robotics and steerable neurovascular guidewires for the minimally invasive treatment of complex vascular conditions.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical AI, Telemedicine, Industrial Robotics
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription, Usage-Based SaaS
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
XCath Comparables
Compare XCath with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sentante | 86% | |
| Remedy Robotics | 85% | |
| Magnendo | 79% |
XCath Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Mar 12, 2026 | ||||
| Series A | Nov 27, 2017 |
XCath Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CE-Ventures | Series A |
| Crescent Enterprises | Series A, Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 27, 2026
Grew 16% QoQ, from 32 to 37 employees.
- May 16, 2026
Monthly visitors grew 84% MoM, reaching 1.1K.
Recent news
Latest coverage and updates
- launchesSep 16, 2026
XCath will launch documentary about Operation Robo Angel on Oct 1st '26.
XCath Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access